Hep C Free Washington (United States)

Hep C Free Washington (United States)

Virus targets
Hepatitis C
Testing and treatment implementation
Health outcomes
WHO region
Region of the Americas
United States of America
Key interventions
Community mobilization
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Screening and diagnosis
Strategic data analysis
Treatment (direct or referral)
Target population
Adults (> 19 years of age)
Incarcerated populations (current and former)
Men who have sex with men
Persons who inject drugs
Pregnant women
Performance target
Care cascade: Evidence of current infection
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Care cascade: Referred for treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
If you would like to have a program page for your program, please create an account and submit program information here

Summary and objectives

Overarching Coordination Goal

1. Ensure implementation of the Hep C Free WA recommendations in order to achieve HCV elimination by 2030

Data and Strategic Information Goals

2. Identify data sources and strategies to strengthen the characterization of HCV disease burden within Washington State.

3. Obtain resources and build capacity for continuous data monitoring, evaluation, quality improvement, and reporting. 4. Identify and track data metrics using currently available data.

5. Determine metrics using data not yet available or accessible.

Community-Based Responses and Interventions Goals

6. Improve access to and use of preventive and health care services in non-clinical settings through expansion and co-location of services.

7. Improve access to and use of clinical care and supportive services by sufficiently scaling coverage and widening the scope of community-based navigation and case management programs.

8. Increase HCV awareness, resources, and education, and reduce stigma.

Clinical Strategies Goals

9. Improve access to and use of clinical care for marginalized populations at risk for or living with HCV through innovative service delivery models.

10. Build the capacity of the health care workforce to diagnose and treat HCV.

11. Improve diagnosis of HCV in primary care settings.

12. Improve HCV disease intervention services.

13.  Improve access to HCV treatment and comprehensive health care.

14. Improve the ability of people taking HCV direct-acting antivirals to complete treatment.

15. Improve follow-up clinical care for people who have completed HCV treatment. 

Last updated